ADIPOQ and metabolic dysfunction-associated steatotic liver disease: This changes in GM have been linked to a reduction in intestinal permeability, LPS levels, and metabolic endotoxemia [115], which may be beneficial in NAFLD [116], as well as lowering weight and inflammation [111,117] and stimulating adiponectin secretion that is associated with NAFLD alleviation [118].